- Home
- GNTA
as of 12-19-2025 1:50pm EST
$1.42
$0.06
-4.05%
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Chart Type:
Time Range:
| Founded: | 2014 | Country: | Italy |
| Employees: | N/A | City: | N/A |
| Market Cap: | 41.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 122.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.28 - $10.00 | Next Earning Date: | 03-30-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered GNTA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 69.60%
69.60%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Genenta Science S.p.A. News
GNTA Breaking Stock News: Dive into GNTA Ticker-Specific Updates for Smart Investing
Compare GNTA vs Leading Stocks
See how GNTA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GNTA Genenta Science S.p.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.